Company
Xenetic Biosciences, Inc. (XBIO)
Standardized SEC financial data for Xenetic Biosciences, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001534525 · NASDAQ · Pharmaceutical Preparations.
Gross margin
0.0%
Operating margin
-95.2%
Net margin
-90.1%
Revenue growth (YoY)
19.0%
Return on equity
-36.3%
Free cash flow
-$2.3M
Debt / equity
0.03×
Current ratio
8.32×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $437K | $1.2M | $1.7M | $2.5M | $2.5M | $3.0M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11.5M | $18.2M | $13.1M | $9.0M | $6.2M | $7.9M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$4.3M | -$4.7M | -$4.6M | -$4.1M | -$2.8M | -$2.3M |
| Investing cash flow |
Get XBIO data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/XBIO/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/XBIO/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"